Medicine

U.K. regulators say people who have a “significant history’’ of allergic reactions shouldn’t receive the new Pfizer COVID vaccine while they investigate two adverse reactions.

The Food and Drug Administration posted its analysis online even as across the Atlantic, Britain on Tuesday began vaccinating its oldest citizens with the Pfizer shots.

The decision could delay the delivery of a second batch of doses until manufacturer Pfizer fulfills other international contracts.

The pandemic put a spotlight on health care workers and inspired many to pursue a career in medicine.

President-elect Joe Biden has said addressing the coronavirus pandemic is his top priority. Here are some of the people he is putting in charge of that big task.

By targeting providers with attacks that scramble and lock up data until victims pay a ransom, hackers can demand lots of money and wreak havoc until they’re paid.

Some panel members and other experts had also grown concerned by comments from Trump administration officials that suggested differing vaccine priorities.

Multiple vaccine candidates must succeed for the world to stamp out the coronavirus pandemic.

The first batch of up to 15,000 doses could come as early as Dec. 11, if FDA grants approval the previous day. Getting an adequate supply will take months.

We talk with Dr. Daniel Monti about the stresses caused by the pandemic, the impact on our bodies and minds, and healthful ways of coping.

The experimental cocktail from the bio-tech company Regeneron is the same drug President Trump got when he was battling the coronavirus earlier this year.

As COVID-19 hospitalizations surge, new data released by the federal government show how many hospitals are struggling with staffing.

Pennsylvania Secretary of Health Rachel Levine said the federal government will distribute the antibodies to healthcare systems in the state.

Trump is doubling down on a novel, unproven injection device, providing more than half a billion dollars in financing for something that is still awaiting FDA approval.

Pfizer's COVID-19 vaccine was found 95% effective in an updated study analysis. The company says it plans to file for FDA emergency use "within days."